BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10559297)

  • 1. T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice.
    Liu L; Usherwood EJ; Blackman MA; Woodland DL
    J Virol; 1999 Dec; 73(12):9849-57. PubMed ID: 10559297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent antigen vaccination in a model gammaherpesvirus infection.
    Usherwood EJ; Ward KA; Blackman MA; Stewart JP; Woodland DL
    J Virol; 2001 Sep; 75(17):8283-8. PubMed ID: 11483773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against murine gamma-herpesvirus infection.
    Woodland DL; Usherwood EJ; Liu L; Flaño E; Kim IJ; Blackman MA
    Viral Immunol; 2001; 14(3):217-26. PubMed ID: 11572633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection.
    Obar JJ; Crist SG; Gondek DC; Usherwood EJ
    J Immunol; 2004 Jan; 172(2):1213-9. PubMed ID: 14707099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine gamma-herpesvirus infection causes V(beta)4-specific CDR3-restricted clonal expansions within CD8(+) peripheral blood T lymphocytes.
    Hardy CL; Silins SL; Woodland DL; Blackman MA
    Int Immunol; 2000 Aug; 12(8):1193-204. PubMed ID: 10917894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells.
    Usherwood EJ; Roy DJ; Ward K; Surman SL; Dutia BM; Blackman MA; Stewart JP; Woodland DL
    J Exp Med; 2000 Oct; 192(7):943-52. PubMed ID: 11015436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection.
    Samreen B; Tao S; Tischer K; Adler H; Drexler I
    Front Immunol; 2019; 10():2984. PubMed ID: 31921215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.
    Wu TT; Usherwood EJ; Stewart JP; Nash AA; Sun R
    J Virol; 2000 Apr; 74(8):3659-67. PubMed ID: 10729142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.
    Liu L; Flaño E; Usherwood EJ; Surman S; Blackman MA; Woodland DL
    J Immunol; 1999 Jul; 163(2):868-74. PubMed ID: 10395681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice.
    Liu H; Andreansky S; Diaz G; Hogg T; Doherty PC
    J Immunol; 2002 Apr; 168(7):3477-83. PubMed ID: 11907108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells.
    Usherwood EJ; Ross AJ; Allen DJ; Nash AA
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():627-30. PubMed ID: 8627250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
    An LL; Whitton JL
    J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages.
    Flaño E; Husain SM; Sample JT; Woodland DL; Blackman MA
    J Immunol; 2000 Jul; 165(2):1074-81. PubMed ID: 10878386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.
    McClellan JS; Tibbetts SA; Gangappa S; Brett KA; Virgin HW
    J Virol; 2004 Jul; 78(13):6836-45. PubMed ID: 15194759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune evasion by gamma-herpesviruses.
    Stevenson PG
    Curr Opin Immunol; 2004 Aug; 16(4):456-62. PubMed ID: 15245739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell reactivity during infectious mononucleosis and persistent gammaherpesvirus infection in mice.
    Flaño E; Hardy CL; Kim IJ; Frankling C; Coppola MA; Nguyen P; Woodland DL; Blackman MA
    J Immunol; 2004 Mar; 172(5):3078-85. PubMed ID: 14978113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latency.
    Weslow-Schmidt J; Ye F; Cush SS; Stuller KA; Blackman MA; Flaño E
    J Virol; 2010 Sep; 84(17):8975-9. PubMed ID: 20592077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection.
    Freeman ML; Lanzer KG; Cookenham T; Peters B; Sidney J; Wu TT; Sun R; Woodland DL; Sette A; Blackman MA
    J Virol; 2010 Mar; 84(6):2881-92. PubMed ID: 20053740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.